Atividade

107251 - Reproductive Health in Gynecology and Obstetrics: Trending Topics

Período da turma: 18/07/2022 a 29/07/2022

Selecione um horário para exibir no calendário:
  
 
Descrição: Geral Opennig in morning
Visit the Department of Obstetrics and Gynecology and welcome

Overview of the picture of infections in pregnancy
How to investigate and diagnose fetal infections?

Arboviruses in Reprodutive System

Discussion of cases of some Yellow Fever, Varicella and Denue during pregnancy

Afternoon: Concerns in Reproduction
Manha: Discussion-
Afternoon:
clinical Cases
Morning: HIV and Brasilian public healt

Follow-up of HIV positive pregnant woman
Of Syphilis infection during pregnancy
Afternoon: General Activity

Pregnancy in Women winth Heart Diseases
Hypertension in pregnancy

Afternoon: Inflammatory pelvic disease and reproduction - Clinical Cases and discussion ( Gynecology)

Morning: HPV outpatien office - Clinical Cases - gynecology
Endometritis and Infertility

Afternoon: General activity

Morning:
Cytomegalovirus (CMV) infection in Pregnancy

Repeat Abosrtment
Toxoplamosis in Pregnancy
Afternoon: General activity

Polycystic ovary syndrome and reproduction – Clinical Cases

Afternoon: Outpatient Gynecology Office – Clinical Cases of Herpes virus
Morning:
Clinical Cases of Sexually Transmitted Diseases and reproductive issues

Repercussion of Sexually Transmitted Disease on Fertility
Afternoon: general activity

Morning:
Pathophysiology and Epidemiology of Gestacional Diabetes
Diagnosis and treatment of gestacional diabetes
Gestacional Diabetes Versus pre-gestational diabetes
Visit to the High Risk Pregnancy Ward

Visit to tje Obstetric Center and Delivery Rooms

Preterm Premature Rupture of Membranes


Referências Bibliograficas

1 - Ginecologia Baseada Em Casos Clínicos. Editores Edmund Chada Baracat, Nilson Roberto de Melo. EDITORA MANOLE LTDA, 2012
2 - Condutas Em Ginecologia Baseadas Em Evidências: Protocolos Assistenciais Clínica Ginecológica Hospital das Clínicas - Edmundo Chada Baracat, Atheneu, 2016
3 - Patnaik SS, Laganà AS, Vitale SG, Butticè S, Noventa M, Gizzo S, Valenti G, Rapisarda AM, La Rosa VL, Magno C, Triolo O, Dandolu V.Etiology, pathophysiology and biomarkers of interstitial cystitis/painful bladder syndrome. Arch Gynecol Obstet. 2017 Apr 8. doi: 10.1007/s00404-017-4364-2.
4 - O'Connell CM, Ferone ME. Chlamydia trachomatis Genital Infections. Microb Cell. 2016 Sep 5;3(9):390-403. doi: 10.15698/mic2016.09.525.
5 - Hill SA, Masters TL, Wachter J. Gonorrhea - an evolving disease of the new millennium.
Microb Cell. 2016 Sep 5;3(9):371-389. doi: 10.15698/mic2016.09.524.
6 - van de Wijgert JH, Jespers V. The global health impact of vaginal dysbiosis. Res Microbiol. 2017 Mar 1. pii: S0923-2508(17)30038-4. doi: 10.1016/j.resmic.2017.02.003.
7 - Wiesenfeld HC. Screening for Chlamydia trachomatis Infections in Women.
N Engl J Med. 2017 Feb 23;376(8):765-773. doi: 10.1056/NEJMcp1412935.
8 - Tsevat DG, Wiesenfeld HC, Parks C, Peipert JF. Sexually transmitted diseases and infertility.
Am J Obstet Gynecol. 2017 Jan;216(1):1-9. doi: 10.1016/j.ajog.2016.08.008.
9 - Rivera Domínguez A, Mora Jurado A, García de la Oliva A, de Araujo Martins-Romeo D, Cueto Álvarez L. Gynecological pelvic pain as emergency pathology. Radiologia. 2017 Mar - Apr;59(2):115-127. doi: 10.1016/j.rx.2016.09.010.
10 - Kwak-Kim J, Song J, Kim MW, Gilman-Sachs A. Zika virus infection and biological treatment for reproductive medicine. Am J Reprod Immunol. 2017 Feb;77(2). doi: 10.1111/aji.12606.
11 - Gradíssimo A, Burk RD. Molecular tests potentially improving HPV screening and genotyping for cervical cancer prevention. Expert Rev Mol Diagn. 2017 Apr;17(4):379-391. doi: 10.1080/14737159.2017.1293525.
12 - Hellner K, Dorrell L. Recent advances in understanding and preventing human papillomavirus-related disease. F1000Res. 2017 Mar 14;6. pii: F1000 Faculty Rev-269. doi: 10.12688/f1000research.9701.1. eCollection 2017.
13 - Elit L, Kennedy EB, Fyles A, Metser U. Follow-up for cervical cancer: a Program in Evidence-Based Care systematic review and clinical practice guideline update. Curr Oncol. 2016 Apr;23(2):109-18. doi: 10.3747/co.23.2742.
14 - Brotherton JM. Human papillomavirus vaccination: where are we now? J Paediatr Child Health. 2014 Dec;50(12):959-65. doi: 10.1111/jpc.12627.
15 - Bolduc P, Roder N, Colgate E, Cheeseman SH. Care of Patients With HIV Infection: Diagnosis and Monitoring. FP Essent. 2016 Apr;443:11-5.
16 - Günthard HF, Saag MS, Benson CA, del Rio C, Eron JJ, Gallant JE, Hoy JF, Mugavero MJ, Sax PE, Thompson MA, Gandhi RT, Landovitz RJ, Smith DM, Jacobsen DM, Volberding PA. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel. JAMA. 2016 Jul 12;316(2):191-210. doi: 10.1001/jama.2016.8900.
17 - Committee Opinion No. 655 Summary: Hepatitis B, Hepatitis C, and Human Immunodeficiency Virus Infections in Obstetrician-Gynecologists. American College of Obstetricians and Gynecologists' Committee on Gynecological Practice. Obstet Gynecol. 2016 Feb;127(2):416-7. doi: 10.1097/AOG.0000000000001308

resence of Cytomegalovirus in urine and blood of pregnant women with primary infection might be associated with fetal infection.
Delforge ML, Costa E, Brancart F, Goldman D, Montesinos I, Zaytouni S, Marchant A, Donner C.
J Clin Virol. 2017 May;90:14-17. doi: 10.1016/j.jcv.2017.03.004

Seroprevalence of cytomegalovirus infection in France in 2010.
Antona D, Lepoutre A, Fonteneau L, Baudon C, Halftermeyer-Zhou F, LE Strat Y, Lévy-Bruhl D.
Epidemiol Infect. 2017 Feb 7:1-8. doi: 10.1017/S0950268817000103.

Primary versus non-primary maternal cytomegalovirus infection as a cause of symptomatic congenital infection - register-based study from Finland.
Puhakka L, Renko M, Helminen M, Peltola V, Heiskanen-Kosma T, Lappalainen M, Surcel HM, Lönnqvist T, Saxen H.


Update on treatment of cytomegalovirus infection in pregnancy and of the newborn with congenital cytomegalovirus.
Rawlinson WD, Hamilton ST, van Zuylen WJ.
Curr Opin Infect Dis. 2016 Dec;29(6):615-624.


Congenital cytomegalovirus infection: management update.
Khalil A, Jones C, Ville Y.
Curr Opin Infect Dis. 2017 Mar 23. doi: 10.1097/QCO.0000000000000368.


Fetal cytomegalovirus infection.
Leruez-Ville M, Ville Y.
Best Pract Res Clin Obstet Gynaecol. 2017 Jan;38:97-107. doi: 10.1016/j.bpobgyn.2016.10.005.
Jacquemard F1, Yamamoto M, Costa JM, Romand S, Jaqz-Aigrain E, Dejean A, Daffos F, Ville Y.Maternal administration of valaciclovir in symptomatic intrauterine cytomegalovirus infection.
BJOG. 2007 Sep;114(9):1113-21. Epub 2007 Jul 6.


Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States
(https://aidsinfo.nih.gov/contentfiles/lvguidelines/perinatalgl.pdf)

MMWR Sexually Transmitted Diseases Treatment Guidelines, 2015
(https://www.cdc.gov/std/tg2015/tg-2015-print.pdf)

Panel on Treatment of HIV­Infected Pregnant Women and Prevention of Perinatal Transmission.
Recommendations for Use of Antiretroviral Drugs in Pregnant HIV­1­Infected Women for Maternal
Health and Interventions to Reduce Perinatal HIV Transmission in the United States.
http://aidsinfo.nih.gov/guidelines/html/3/perinatal­guidelines/0/ (Accessed on October 26, 2016).
Burns DN, Landesman S, Muenz LR, et al. Cigarette smoking, premature rupture of membranes, and
vertical transmission of HIV­1 among women with low CD4+ levels. J Acquir Immune Defic Syndr 1994;
7:718.
Matheson PB, Thomas PA, Abrams EJ, et al. Heterosexual behavior during pregnancy and perinatal
transmission of HIV­1. New York City Perinatal HIV Transmission Collaborative Study Group. AIDS
1996; 10:1249.
Rodriguez EM, Mofenson LM, Chang BH, et al. Association of maternal drug use during pregnancy with
maternal HIV culture positivity and perinatal HIV transmission. AIDS 1996; 10:273.
Bulterys M, Landesman S, Burns DN, et al. Sexual behavior and injection drug use during pregnancy
and vertical transmission of HIV­1. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 15:76.
Turner BJ, Hauck WW, Fanning TR, Markson LE. Cigarette smoking and maternal­child HIV
transmission. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 14:327.
Landesman SH, Kalish LA, Burns DN, et al. Obstetrical factors and the transmission of human
immunodeficiency virus type 1 from mother to child. The Women and Infants Transmission Study. N
Engl J Med 1996; 334:1617.
Mongelli M, Wilcox M, Gardosi J. Estimating the date of confinement: ultrasonographic biometry versus
certain menstrual dates. Am J Obstet Gynecol 1996; 174:278.
Neilson JP. Ultrasound for fetal assessment in early pregnancy. Cochrane Database Syst Rev 2000;
:CD000182.
Yang H, Kramer MS, Platt RW, et al. How does early ultrasound scan estimation of gestational age lead
to higher rates of preterm birth? Am J Obstet Gynecol 2002; 186:433.
Gale HB, Gitterman SR, Hoffman HJ, et al. Is frequent CD4+ T­lymphocyte count monitoring necessary
for persons with counts >=300 cells/μL and HIV­1 suppression? Clin Infect Dis 2013; 56:1340.
Tuomala RE, Kalish LA, Zorilla C, et al. Changes in total, CD4+, and CD8+ lymphocytes during
pregnancy and 1 year postpartum in human immunodeficiency virus­infected women. The Women and
Infants Transmission Study. Obstet Gynecol 1997; 89:967.
Miotti PG, Liomba G, Dallabetta GA, et al. T lymphocyte subsets during and after pregnancy: analysis in
human immunodeficiency virus type 1­infected and ­uninfected Malawian mothers. J Infect Dis 1992;
165:1116.
Mehta S, Manji KP, Young AM, et al. Nutritional indicators of adverse pregnancy outcomes and motherto­child
transmission of HIV among HIV­infected women. Am J Clin Nutr 2008; 87:1639.
Plasma HIV RNA is monitored frequently during pregnancy to confirm attainment and maintenance of
viral suppression. Close monitoring is desired to confirm the adherence to and effectiveness of the
patient’s ART regimen since higher levels of HIV RNA are associated with increased risk of perinatal
transmission of HIV infection. (See 'Viral load measurement' above.)

Prior to delivery, the HIV­infected woman should be counseled that breastfeeding is not recommended by
the United States Public Health Service, due to concerns regarding risk of breast milk transmission of
HIV. (See 'Counseling regarding breastfeeding' above.)

10/04/2017 Prenatal evaluation of the HIV­infected woman in resource­rich settings ­ UpToDate
https://www.uptodate.com/contents/prenatal­evaluation­of­the­hiv­infected­woman­in­resource­rich­settings/print?source=search_result&search=hiv%20… 9/10
Polis CB, Shah SN, Johnson KE, Gupta A. Impact of maternal HIV coinfection on the vertical
transmission of hepatitis C virus: a meta­analysis. Clin Infect Dis 2007; 44:1123.
Centers for Disease Control and Prevention. Guidelines for vaccinating pregnant women, Hepatitis A.
2013. http://www.cdc.gov/vaccines/pubs/preg­guide.htm#hepa (Accessed on May 08, 2014).
Elzi L, Schlegel M, Weber R, et al. Reducing tuberculosis incidence by tuberculin skin testing, preventive
treatment, and antiretroviral therapy in an area of low tuberculosis transmission. Clin Infect Dis 2007;
44:94.
Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus:
principles of therapy and revised recommendations. Centers for Disease Control and Prevention.
MMWR Recomm Rep 1998; 47:1.
Mwapasa V, Rogerson SJ, Kwiek JJ, et al. Maternal syphilis infection is associated with increased risk of
mother­to­child transmission of HIV in Malawi. AIDS 2006; 20:1869.
ACOG practice bulletin. Perinatal viral and parasitic infections. Number 20, September 2000. (Replaces
educational bulletin number 177, February 1993). American College of Obstetrics and Gynecologists. Int
J Gynaecol Obstet 2002; 76:95.
Fowler KB, Stagno S, Pass RF, et al. The outcome of congenital cytomegalovirus infection in relation to
maternal antibody status. N Engl J Med 1992; 326:663.
Kovacs A, Schluchter M, Easley K, et al. Cytomegalovirus infection and HIV­1 disease progression in
infants born to HIV­1­infected women. Pediatric Pulmonary and Cardiovascular Complications of
Vertically Transmitted HIV Infection Study Group. N Engl J Med 1999; 341:77.
Quinn TC, Piot P, McCormick JB, et al. Serologic and immunologic studies in patients with AIDS in North
America and Africa. The potential role of infectious agents as cofactors in human immunodeficiency
virus infection. JAMA 1987; 257:2617.

Pickering LK, Baker CJ, Freed GL, et al. Immunization programs for infants, children, adolescents, and
adults: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2009;
49:817.
Panel on Opportunistic Infections in HIV­Infected Adults and Adolescents. Guidelines for the prevention
and treatment of opportunistic infections in HIV­infected adults and adolescents: Recommendations from
the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine
Association of the Infectious Diseases Society of America.
http://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf (Accessed on September 21, 2016).
Ford N, Shubber Z, Jao J, et al. Safety of cotrimoxazole in pregnancy: a systematic review and metaanalysis.
J Acquir Immune Defic Syndr 2014; 66:512.
United States Food and Drug Administration Safety Communication: oral fluconazole in pregnancy
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm497
656.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery (Accessed on April 26,
2016).
Mølgaard­Nielsen D, Svanström H, Melbye M, et al. Association Between Use of Oral Fluconazole
During Pregnancy and Risk of Spontaneous Abortion and Stillbirth. JAMA 2016; 315:58.
Antiretroviral Pregnancy Registry Steering Committee (2012). Antiretroviral Pregnancy Registry
Steering Committee. Antiretroviral pregnancy registry international interim report for 1 Jan 1989 ­ January 2012. Wilmington, NC: Registry Coordinating Center; 2010. http://www.APRegistry.com
(Accessed on July 16, 2012).
Ekoukou D, Khuong­Josses MA, Ghibaudo N, et al. Amniocentesis in pregnant HIV­infected patients.
Absence of mother­to­child viral transmission in a series of selected patients. Eur J Obstet Gynecol
Reprod Biol 2008; 140:212.
10/04/2017 Prenatal evaluation of the HIV­infected woman in resource­rich settings ­ UpToDate
https://www.uptodate.com/contents/prenatal­evaluation­of­the­hiv­infected­woman­in­resource­rich­settings/print?source=search_result&search=hiv%2… 10/10
Mandelbrot L, Jasseron C, Ekoukou D, et al. Amniocentesis and mother­to­child human
immunodeficiency virus transmission in the Agence Nationale de Recherches sur le SIDA et les
Hépatites Virales French Perinatal Cohort. Am J Obstet Gynecol 2009; 200:160.e1.
Coll O, Suy A, Hernandez S, et al. Prenatal diagnosis in human immunodeficiency virus­infected
women: a new screening program for chromosomal anomalies. Am J Obstet Gynecol 2006; 194:192.
Somigliana E, Bucceri AM, Tibaldi C, et al. Early invasive diagnostic techniques in pregnant women who
are infected with the HIV: a multicenter case series. Am J Obstet Gynecol 2005; 193:437.
Maiques V, García­Tejedor A, Perales A, et al. HIV detection in amniotic fluid samples. Amniocentesis
can be performed in HIV pregnant women? Eur J Obstet Gynecol Reprod Biol 2003; 108:137.
Shapiro RL, Holland DT, Capparelli E, et al. Antiretroviral concentrations in breast­feeding infants of
women in Botswana receiving antiretroviral treatment. J Infect Dis 2005; 192:720.
Colebunders R, Hodossy B, Burger D, et al. The effect of highly active antiretroviral treatment on viral
load and antiretroviral drug levels in breast milk. AIDS 2005; 19:1912.
Schneider S, Peltier A, Gras A, et al. Efavirenz in human breast milk, mothers', and newborns' plasma.
J Acquir Immune Defic Syndr 2008; 48:450.
Rezk NL, White N, Bridges AS, et al. Studies on antiretroviral drug concentrations in breast milk:
validation of a liquid chromatography­tandem mass spectrometric method for the determination of 7 antihuman
immunodeficiency virus medications. Ther Drug Monit 2008; 30:611.

WHO.Dengue and Dengue haemorrhagic fever. Factsheet No.117. Geneva: World health organization. 2008

Gulati S, Maheshwari A. Typical manifestations of dengue. Trop Med Int Health. 2007;12:1087-1095.doi: 10.1111/j.1365-3156.2007.01891.x

Solomon T, Dung NM, Vaughn DW, Kneen R, Thao LT, Raengsakulrach B, et al Neurological manifestations of dengue infection. Lancet. 2000; 355:1053-1059.doi 10.1016/S02140-6736(00)02036-5.

Cam BV, Fonsmark L, Hue NB, Phuong NT, Poulsen A, Heegaard ED. Prospective supplements.Min Ginecol. 1997;49:571-576

Restrpo BN, Isaza DM, Salazar CL, Ramírez JL, Upegui GE, Ospina M, et al. Prenatal and postnatal effects of dengue infection during pregnancy. Biomedica. 2003;23(4):416-423.doi:10.7705/biomedica.v 23i4.1236

Tan PC, Rajasingam G, DEvi S, Omar SZ. Dengue infection in pregnancy: prevalence, vertical trasmission, and pregnancy outcome. Obstet Gynecol. 2008;111(5):1111-1117. doi: 10.1097/AOG.0b013e31816a49fc

A rare case of dengue encephalopathy complicating a term pregnancy.

Carga Horária:
60 horas
Tipo: Obrigatória
Vagas oferecidas: 10
 
Ministrantes: Aluisio Augusto Cotrim Segurado
Arlete Gianfaldoni
Carolina Burgarelli Testa
Edmund Chada Baracat
Eliane Azeka Hase
Fabio de Rose Ghilardi
Gustavo Arantes Rosa Maciel
Iara Moreno Linhares
Isabel Cristina Esposito Sorpreso
Joelma Queiroz Andrade
Jorge Milhem Haddad
José Maria Soares Júnior
Lana Maria de Aguiar
Marco Antonio Borges Lopes
Marco Aurélio Knippel Galletta
Maria Rita de Figueiredo Lemos Bortolotto
Maricy Tacla Alves Barbosa
Rafaela Alkmin da Costa
Ricardo dos Santos Simões
Rossana Pulcineli Vieira Francisco
Ursula Trovato Gomez
Venina Isabel Poco Viana Leme de Barros


 
 voltar

Créditos
© 1999 - 2024 - Superintendência de Tecnologia da Informação/USP